Emerging Markets On Executives’ Minds At JPM15
This article was originally published in PharmAsia News
Several top executives from major multinationals made comments on emerging market strategies at the JP Morgan Healthcare Conference in San Francisco Jan. 12-15 that piqued the interest of PharmAsia News. Among them, GSK said it was looking for a broad product portfolio, Lilly noted it had doubled its sales in China and Becton Dickinson highlighted the need to develop targeted products.
You may also be interested in...
GlaxoSmithKline has joined a growing list of big pharma companies expanding in China, launching a research and development center based in Shanghai, the company announced May 24
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.